DB1113 - 99%, high purity , CAS No.2769753-53-7

  • ≥99%
Item Number
D650709
Grouped product items
SKUSizeAvailabilityPrice Qty
D650709-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,450.90
D650709-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$340.90
D650709-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$850.90

Basic Description

Specifications & Purity≥99%
Biochemical and Physiological MechanismsDB1113 (Example 24) is a bifunctional compound targeted protein degradation of kinases. DB1113 degrades ABL1 , ABL2, BLK, CDK11B, CDK4 , CSK, EPHA3 , FER, GAK, LIMK1 , MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2 , MAPKAP
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
Product Description

DB1113 (Example 24) is a bifunctional compound targeted protein degradation of kinases. DB1113 degrades ABL1 , ABL2, BLK, CDK11B, CDK4 , CSK, EPHA3 , FER, GAK, LIMK1 , MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2 , MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1 , RPS6KA1, RPS6KA3, SIK2 , SIK3 , STK35, TNK2, and ULK1 . DB1113 can be used for research of disease or disorder mediated by aberrant kinase activity

Form:Solid

IC50& Target:CDK4 CDK11B MAP4K2 SIK2 SIK3 MAP4K5 HPK1 GLK/MAP4K3 ULK1 LIMK1

Names and Identifiers

Canonical SMILES O=C1N(C2=CC(NC(C3=CC(C(F)(F)F)=CC=C3)=O)=CC=C2C)CC4=CN=C(NC5=CN=C(N6CCN(CC6)CCCCC(N[C@@H](C(C)(C)C)C(N7[C@@H](C[C@H](C7)O)C(N[C@H](C8=CC=C(C9=C(N=CS9)C)C=C8)C)=O)=O)=O)C=C5)N=C4N1C
Molecular Weight 1144.31

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilityDMSO : 60 mg/mL (52.43 mM; Need ultrasonic)

Related Documents

Solution Calculators